Table 2. LAPTM4B genotype and clinicopathological variables.
Variables | LAPTM4B genotype | P value | |
*1/1 *1/2+*2/2 | |||
Age | 0.6856 | ||
≤40 | 35 | 42 | |
>40 | 54 | 76 | |
Pathological type | 0.1713 | ||
Ductal | 75 | 95 | |
others | 9 | 22 | |
Tumor size(cm) | 0.3872 | ||
≤2 | 51 | 75 | |
>2 | 39 | 43 | |
Histological grade | 0.0027 | ||
Low | 74 | 72 | |
High | 9 | 31 | |
Lymph node metastasis | 0.0322 | ||
No | 62 | 61 | |
Yes | 21 | 43 | |
ER status | 0.7579 | ||
Negative | 40 | 9 | |
Positive | 59 | 36 | |
PR status | 0.179 | ||
Negative | 29 | 37 | |
Positive | 51 | 75 | |
C-erbB2 status | 0.549 | ||
Negative | 56 | 82 | |
Positive | 24 | 30 | |
Triple-negative status | 0.3844 | ||
No | 74 | 90 | |
Yes | 16 | 28 |
LAPTM4B, lysosome-associated protein transmembrane 4 beta; ER, estrogen receptor;
PR, progestogen receptor; Triple-negative, ER, PR and C-erbB2 negative.